Autoimmunities for T1D, Celiac Co-Occur More Than Expected

This article originally appeared here.
Share this content:
Autoimmunities for T1D, Celiac Co-Occur More Than Expected
Autoimmunities for T1D, Celiac Co-Occur More Than Expected

TUESDAY, Oct. 10, 2017 (HealthDay News) -- Co-occurrence of type 1 diabetes (T1D) and celiac disease (CD) autoimmunities significantly exceeds the expected rate, according to a study published online Oct. 10 in Pediatrics.

William Hagopian, M.D., Ph.D., from the Pacific Northwest Research Institute in Seattle, and colleagues enrolled 8,676 children at high genetic risk of T1D and CD and analyzed data from 5,891 for a median follow-up of 66 months. The authors analyzed demographic factors and human leukocyte antigen (HLA)-DR-DQ, as well as genotypes for HLA-DPB1 and five non-HLA loci conferring risk of T1D and CD. From age 3 to 48 months, development of persistent islet autoantibodies (IAs) and tissue transglutaminase autoantibodies (tTGAs) and clinical disease was assessed quarterly.

The researchers found that IAs alone, tTGAs alone, and both appeared in 367, 808, and 90 children, respectively, with co-occurrence significantly exceeding the expected rate. Usually, but not always, IAs preceded tTGAs. Increased risk of tTGAs was seen with IAs preceding tTGAs (hazard ratio, 1.48). Children with a T1D family history, HLA-DR3/4, and single-nucleotide polymorphism rs3184504 at SH2B3 had significantly greater co-occurrence after adjustment for country, sex, family history, and all other genetic loci (hazard ratios, 2.8, 1.94, and 1.53). All analyzed factors did not fully account for observed co-occurrence.

"Co-occurrence is greater than explained by demographic factors and extensive genetic risk loci, indicating that shared environmental or pathophysiological mechanisms may contribute to the increased risk," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Doctors Urged to Speak With Patients About Firearms

Doctors Urged to Speak With Patients About Firearms

Making a public commitment is encouraged as a positive action that physicians can take

Machine Learning Model Predicts Risk of Upgrade to Breast CA

Machine Learning Model Predicts Risk of Upgrade to ...

Model can predict risk of upgrade of high-risk breast lesions to cancer using traditional, text features

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

Glycemic Control Up With Oral Semaglutide in Type ...

Phase 3 studies next to assess longer-term/clinical outcomes, safety

is free, fast, and customized just for you!

Already a member?

Sign In Now »